PTGS1 and stroke disorder: In clinical practice, diclofenac, one kind of NSAIDs (inhibiting COX-1 and COX-2), is used as the most effective for OA treatment [4] and increases the rating of the risk of a cardiovascular event by fourfold, stroke by threefold, and all-cause death by twofold [13].